Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

被引：18
作者：
Kow, Chia Siang [1 ]
Capstick, Toby [2 ]
Hasan, Syed Shahzad [3 ,4 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] St James Univ Hosp, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[3] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[4] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
ALLERGY | 2021年 / 76卷 / 03期
关键词：
D O I：
10.1111/all.14589
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：959 / 960
页数：2
相关论文
共 5 条
  • [1] Common concerns in managing bronchial asthma during the COVID-19 pandemic
    Chai, C-S.
    Liam, C-K.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (07) : 750 - 752
  • [2] Chhiba KD, 2020, J ALLERGY CLIN IMMUN, V6749, P30840
  • [3] Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
    Halpin, David M. G.
    Singh, Dave
    Hadfield, Ruth M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (05)
  • [4] COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
    Heffler, Enrico
    Detoraki, Aikaterini
    Contoli, Marco
    Papi, Alberto
    Paoletti, Giovanni
    Malipiero, Giacomo
    Brussino, Luisa
    Crimi, Claudia
    Morrone, Daniela
    Padovani, Marianna
    Guida, Giuseppe
    Gerli, Alberto Giovanni
    Centanni, Stefano
    Senna, Gianenrico
    Paggiaro, Pierluigi
    Blasi, Francesco
    Canonica, Giorgio Walter
    [J]. ALLERGY, 2021, 76 (03) : 887 - 892
  • [5] Schultze A, 2020, INHALED CORTICOSTERO, V6
1